상단영역

본문영역

  • 기자명 Serena
  • Tech & Bio
  • Published 2021.01.13 01:09

[CES 2021 All Digital] AI gives you a chance to prevent Alzheimer's Dementia

AI brain mapping with EEG discovered Alzheimer's brainwave and could detect preclinical Alzheimer's dementia(AD). This has been enabled by an innovative AI technology of iMediSync in brain mapping.

iMediSync, a biotech startup launched EEG digital biomarker for early detection of Alzheimer's dementia on their AI cloud platform, iSyncBrain®. With AI analytics and brain mapping techniques, they also serve personalized NIR-LED neuromodulation using their upcoming novel headset, iSyncWave™ to enhance neuronal activity.

Brain waves slow down overall as the brain degenerates. These preclinical phenomena are difficult to detect just by inspection. But Artificial Intelligence(AI) technology can do this by deep learning.

AI-driven early detection and therapeutic platform for optimal brain health

iSyncBrain® MCI classifier screens and discriminates Alzheimer or non-Alzheimer type of  amnestic mild cognitive impairment (MCI) to prevent dementia at preclinical stage. This endured multicenter clinical trials with results of over 90% accuracy.

AI cloud based-EEG brain mapping results of normal vs. aMCI (preclinical AD) by iSyncBrain

The Company plans to expand its capability addressing patient optimal health. iMediSync will showcase a groundbreaking EEG (electroencephalogram) brain mapping and LED-therapeutic device, iSyncWave™ at CES 2021. iMedisync will demonstrate its version of virtual care - allowing healthcare providers to monitor patients remotely. In addition, iMediSync is conducting multiple research efforts in the development of new biomarkers for Coma, ADHD, Depression, Parkinson's Disease, Children Developmental Disorders and other neurological-based diseases through its advanced EEG analysis.

The global news network AVING News has dispatched reporters to CES for 15 consecutive years since 2006, reporting the most number of news globally. After exhibition, it will hold CES 2021 Review Conference to share insight on CES at the end of January.

* MIK (Made in Korea) project in CES 2019-2020 to promote Korean companies to the world
* BEST OF CES since 2015 to select outstanding products by each sector
* The first CES review event CES Review Conference held every year since 2015

→ Go to CES 2021 All Digital special news page

Contact Information:

  • iMediSync, Inc.
  • Company Address: 5th Floor, 175 Yeoksam-ro, Gangnam-gu, Seoul, Republic of Korea
  • Phone Number: +82-2-747-7422
  • Email: isyncbrain@imedisync.com

This article is a summary of the press release.

하단영역